Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
biopharma-reporter
17h
Pricing and logistics: The challenges of getting mpox vaccines to the front line
Although vaccines already exist to prevent mpox, high prices and the risk of side effects make it difficult to roll them out ...
biopharma-reporter
23h
Cellevate bags €3.2 million to smash viral vector manufacturing bottleneck
The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...
biopharma-reporter
21h
Novartis’ Kisqali receives FDA approval to reduce the risk of breast cancer recurrence
Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Makes MLB history
Cancels appearance w/ Duda
Boy kills bear, saves father
Collapse hazard recall
To get a second moon
Ban called for in TX schools
Vows to remain in race
30 yrs in prison for assault
COVID, Wuhan market link
Families lose appeal
Dow, S&P hit record highs
Gun case sentencing delay
Overdose deaths drop in US
Man charged for threats
Joins Motion Picture Assn.
Hails economic progress
Rally attendees injured
EU warns Apple
Existing home sales drop
FTC on privacy controls
160M euros to Ukraine
Retires after 17 seasons
US healthcare system falls
UN backs Palestine
Brazil threatens daily fines
Deal to build new arena
AC mayor, wife indicted
To receive Holbrooke award
Los Angeles dengue cases
Retaliated against scientists
NYC subway joyride arrest
US jobless claims fall
Feedback